Skip to main content

The complete cancer genome will allow early detection and personalized treatment of this disease




Press & Communications Section Head
Tel.+34 93 40 37255

Various media channels have reported on the Pan-Cancer Project, which has involved the Biomedical Genomics Lab at the Institute for Research in Biomedicine (IRB Barcelona). 

The journal Nature has published a set of 23 articles that describe the most comprehensive genomic map of 38 types of cancer to date.  “It’s the first time that the complete genomes of tumours has been sequenced,” says Abel González, researcher in IRB Barcelona’s Biomedical Genomics Lab.

SER radio station has also interviewed Núria López-Bigas, head of the aforementioned lab. The researcher explains that one of the conclusions of the study is that “cancer is a genetic disease—a disease caused by gene mutations”. She goes on to say that the goal of this work is to analyse what causes tumours and to understand how cancer cells evolve.

Link to: ABC

Link to: ARA

Link to:

Link to: El Punt Avui

Link to: CCMA

Link to:

Link to: El Confidencial

Link to: Cadena SER

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).